News - Vaccines, Asia-Pacific


Current filters:


Popular Filters

1 to 25 of 32 results

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline


Japanese drug major Daiichi Sankyo has updated on the H5N1 influenza vaccine project, revealing that…

Asia-PacificDaiichi SankyoJapanPharmaceuticalProductionVaccines

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan


Japanese drug major Astellas Pharma and partner UMN Pharma have announced promising summary results for…

Asia-PacificASP7374Astellas PharmaGastro-intestinalsIrribowMarkets & MarketingPharmaceuticalResearchUMN PharmaVaccines

Takeda to sell BIKEN varicella vaccine in Japan

Takeda to sell BIKEN varicella vaccine in Japan


Japan’s largest drugmaker Takeda Pharmaceutical says it has reached agreement with the Research Foundation…

Asia-PacificMarkets & MarketingPharmaceuticalTakeda PharmaceuticalsVaccines

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted


China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

China bans BioKangtai hepatitis B vaccine


Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine…


New Zealand proposals for influenza vaccines


New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

Novartis MenB vaccine approved in Australia


Swiss drug major Novartis (NOVN: VX) revealed this morning (August 15) that the Australian Therapeutic…


India's Zydus and IDRI to develop new vaccine for deadly parasitic disease


India's fourth largest health care group Zydus and non-profit global health organization Infectious Disease…

Asia-PacificPharmaceuticalResearchVaccinesZydus Cadila

Lupin to market MSD vaccine in India


US pharma giant Merck & Co (NYSE: MRK), known as MSD outside of North America, has entered into an India…


Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA


The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

India-developed rotavirus vaccine demonstrates strong efficacy


In a public-private partnership, the Indian government's Department of Biotechnology (DBT) and Bharat…

Asia-PacificBharat BiotechPharmaceuticalResearchROTAVACVaccines

Sinovac rockets on strong data for Enterovirus 71 vaccine


Chinese vaccines maker Sinovac Biotech Ltd. (Nasdaq: SVA) saw its shares leap 53% to $4.88 in morning…

Asia-PacificEnterovirus 71PharmaceuticalRegulationResearchSinovacVaccines

Sanofi eyes big plans for China


French pharmaceutical giant Sanofi (Euronext: SAN) plans to complete building a large plant for the production…

Asia-PacificPharmaceuticalProductionSanofiSanofi PasteurVaccines

GlaxoSmithKline and Biological E set up JV to develop combination vaccine


UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into…

Asia-PacificBiological E LtdGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResearchVaccines

China gains WHO designation for biological products center


China's Institute for Biological Product Control (IBPC) of the National Institutes for Food and Drug…


Japan's seasonal flu vaccines market analysis


The Japanese influenza vaccine market is valued at around $702 million in 2012, according to a new report…

Anti-viralsAsia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalSanofiVaccines

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan


Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585)…

Asia-PacificBiotechnologyCatalent Pharma SolutionsGenericsProductionResearchUMN PharmaVaccines

Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis


Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) has launched its Imojev vaccine against…

Asia-PacificImojevMarkets & MarketingPharmaceuticalSanofiSanofi PasteurVaccines

GSK's Synflorix to be used for GAVI pneumococcal vaccines program in Pakistan


World's largest pneumococcal mass vaccination program is expected to protect up to 4.8 million children…

Asia-PacificGlaxoSmithKlineHealthcareMarkets & MarketingPharmaceuticalSynflorixVaccines

Biological launches Japanese Encephalitis vaccine JEEV in India


Austria's Intercell AG (VSE: ICLL) that its partner, the Indian vaccines and pharma company Biological…

Asia-PacificBiological E LtdBiotechnologyIntercellJEEVMarkets & MarketingPharmaceuticalVaccines

Australia extends HPV vaccine to schoolboys


In what is claimed "a world first" by the Department of Health and Ageing, Australian schoolboys will…

Asia-PacificGardasilHealthcareMerck & CoOncologyPharmaceuticalVaccines

New vaccine uptake drives market growth in India


In India, the government-sponsored Universal Immunization Program procures vaccines at very low prices,…

Asia-PacificMarkets & MarketingPharmaceuticalVaccines

CSL Biotherapies indentifies likely reason for Fluvax problems


Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

1 to 25 of 32 results

Back to top